GO:0072016 glomerular parietal epithelial cell development: Development, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072016 describes the progression of a glomerular parietal epithelial cell (PEC) from formation to mature structure; PECs line Bowman's capsule and form tight junctions that act as a barrier to protein transport.
• PECs are not passive bystanders: they are interdependent with podocytes during glomerular development and disease, and their dysfunction is a central feature of crescentic glomerulonephritis.
• Loss of PEC density is linked to podocyte depletion and to predictors of kidney disease progression in human kidneys.
• PECs can become activated, migrate, and contribute to crescent formation in autoimmune kidney disease through spatiotemporal crosstalk with immune and renal cells.
• Single-cell RNA sequencing has localized the ALDH1A2-mediated retinoic acid synthetic pathway to glomerular parietal epithelial cells, highlighting a candidate maturation signal.
• Studying GO:0072016 requires ex vivo outgrowth assays, lineage tracing, single-cell transcriptomics, and CRISPR models that test candidate genes in PEC activation and barrier function.
Description
Glomerular parietal epithelial cell development (GO:0072016) is the biological process by which a glomerular parietal epithelial cell (PEC) progresses over time from its formation to its mature structure. PECs are specialized epithelial cells that form tight junctions as a barrier to protein transport, and they line the parietal layer of Bowman's capsule. Because the glomerular filtration barrier is a composite of podocytes, endothelial cells, and basement membrane, PEC development and maintenance are increasingly recognized as essential for normal glomerular architecture and for the response to injury. The term is therefore of interest to nephrology researchers, developmental biologists, and anyone modeling glomerular disease in vitro or in vivo.
glomerular parietal epithelial cell development At A Glance
| GO ID | GO:0072016 |
|---|---|
| GO term | glomerular parietal epithelial cell development |
| Ontology | biological_process |
| Synonym | Bowman's capsule development |
| Definition | The process whose specific outcome is the progression of a glomerular parietal epithelial cell over time, from its formation to the mature structure. Glomerular parietal epithelial cells are specialized epithelial cells that form tight junctions as a barrier to protein transport. |
| Major function | Formation and maturation of PECs that line Bowman's capsule and contribute to the protein transport barrier |
| Related cell type | Glomerular parietal epithelial cell (PEC) |
| Related structure | Bowman's capsule / glomerulus |
| Disease relevance | Crescentic glomerulonephritis, podocyte depletion, kidney disease progression |
What Is GO:0072016?
In practical terms, GO:0072016 covers the cellular and molecular events that build a mature glomerular parietal epithelial cell. It begins with the specification and formation of the PEC lineage and proceeds through the establishment of a polarized epithelial monolayer, junctional complexes (including tight junctions), and the mature PEC phenotype that contributes to the protein transport barrier of Bowman's capsule. The QuickGO synonym Bowman's capsule development reflects this anatomical context. The process is not static: mature PECs retain the capacity for activation, migration, and crosstalk with podocytes and other glomerular cells, which is why the term is relevant to both development and disease.
Why Is glomerular parietal epithelial cell development Important in Cell Biology?
GO:0072016 matters because PECs are active participants in glomerular health and disease rather than a simple lining. Podocyte-PEC interdependence shapes glomerular development and disease outcomes, and PEC dysfunction is a recognized driver of crescentic glomerulonephritis. In human kidneys, decreased PEC density is linked to podocyte depletion and to predictors of kidney disease progression. Crosstalk between glomeruli and tubules further places PEC biology in the broader context of nephron injury and repair. Understanding this process is therefore essential for interpreting glomerular pathology and for designing cell models that test candidate genes causally.
• PECs form tight junctions that act as a barrier to protein transport, contributing to the glomerular filtration barrier.
• Podocyte-PEC interdependence influences glomerular development and disease progression.
• PEC dysfunction is a central mechanism in crescentic glomerulonephritis.
• Decreased PEC density is linked to podocyte depletion and predictors of kidney disease progression in human kidneys.
• PEC activation and outgrowth can be measured ex vivo, providing a functional readout of the process.
• Single-cell RNA sequencing has localized the ALDH1A2-mediated retinoic acid synthetic pathway to PECs, suggesting a maturation-relevant signal.
• Spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney disease.
• Glomerular-tubular crosstalk highlights how PEC biology integrates with broader nephron injury responses.
• PEC biology is relevant to regenerative and repair responses after glomerular injury.
• CRISPR models enable causal testing of candidate genes in PEC development and activation.
What Happens During glomerular parietal epithelial cell development?
Specification and formation of the PEC lineage
In simple terms: This is the step where the cell that will become a parietal epithelial cell is first set aside and begins its journey.
GO:0072016 begins with the formation of the glomerular parietal epithelial cell. During glomerular development, PECs arise in close spatial and temporal relationship with podocytes, and their interdependence is a recurring theme in glomerular development and disease. The process is best understood as a progression from an early PEC precursor to a mature, polarized epithelial cell that occupies the parietal layer of Bowman's capsule.
Establishment of the parietal epithelial monolayer and tight junctions
In simple terms: The cells organize into a neat sheet and build seals between themselves so proteins do not leak through.
A defining outcome of GO:0072016 is the mature PEC structure, including tight junctions that act as a barrier to protein transport. This barrier function is part of the specialized epithelial phenotype of PECs. The mature PEC monolayer lines Bowman's capsule, and its integrity is relevant to the composite glomerular filtration barrier.
PEC maturation and metabolic specialization
In simple terms: Mature parietal cells switch on specific metabolic programs that support their specialized job.
Single-cell RNA sequencing data have located the ALDH1A2-mediated retinoic acid synthetic pathway to glomerular parietal epithelial cells, indicating that mature PECs possess a distinct metabolic and signaling profile. This finding supports the view that PEC maturation involves more than structural changes and includes specialized enzymatic pathways that may influence the surrounding glomerular niche.
PEC activation, migration, and crosstalk with podocytes
In simple terms: Even after they mature, parietal cells can wake up, move, and talk to neighboring cells when the glomerulus is injured.
PECs are not terminally inert. Podocyte-PEC interdependence is a key concept in glomerular development and disease, and PEC activation can be studied ex vivo using glomerular outgrowth assays. In crescentic glomerulonephritis, PEC dysfunction contributes to crescent formation, and spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney disease. These observations link the mature PEC state to injury responses that are part of the broader biology of GO:0072016.
PEC density, podocyte depletion, and disease progression
In simple terms: When parietal cells are lost, the kidney tends to do worse, and this can be measured in human tissue.
In human kidneys, decreased parietal epithelial cell density is linked to podocyte depletion and to predictors of kidney disease progression. This connects the developmental and homeostatic process described by GO:0072016 to clinically relevant outcomes. Crosstalk between glomeruli and tubules further indicates that PEC changes are integrated into nephron-level injury and repair responses.
Key Genes Involved in GO:0072016 glomerular parietal epithelial cell development
The following genes and proteins have been implicated in glomerular parietal epithelial cell biology, podocyte-PEC interdependence, PEC activation, or crescent formation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ALDH1A2 | Retinoic acid synthesis in PECs | Single-cell RNA sequencing localized this pathway to PECs |
| NPHS2 (podocin) | Podocyte slit diaphragm protein relevant to podocyte-PEC interdependence | Podocyte injury and PEC crosstalk in glomerular disease |
| NPHS1 (nephrin) | Podocyte slit diaphragm protein relevant to podocyte-PEC interdependence | Podocyte depletion and PEC density relationships |
| WT1 | Podocyte and glomerular developmental transcription factor | Glomerular development and podocyte-PEC interdependence |
| PAX2 | Embryonic epithelial transcription factor | PEC lineage and glomerular development context |
| CD44 | PEC activation marker | Activated PEC identification in crescentic disease |
| CD24 | PEC surface marker | PEC identification and outgrowth assays |
| ANXA2 | PEC-associated protein | PEC activation and migration studies |
| VIM (vimentin) | Cytoskeletal marker of activated PECs | PEC activation and crescent formation |
| ACTA2 (alpha-SMA) | Myofibroblast-like activation marker | PEC activation in crescentic glomerulonephritis |
| CXCR4 | Chemokine receptor implicated in PEC migration | PEC activation and crescent biology |
| MIF | Inflammatory mediator in crescentic disease | Immune-renal crosstalk in crescent formation |
| TGFB1 | Profibrotic cytokine | PEC activation and glomerular injury responses |
| WNT4 | Developmental signaling ligand | Glomerular development and PEC biology |
| NOTCH1 | Developmental signaling receptor | Podocyte-PEC interdependence and glomerular disease |
| VEGFA | Angiogenic and permeability factor | Glomerular crosstalk and injury responses |
| REN | Renin, renin-angiotensin system component | Glomerular-tubular crosstalk and kidney disease progression |
How Is glomerular parietal epithelial cell development Regulated?
The regulation of GO:0072016 is best described as context-dependent and incompletely resolved. Podocyte-PEC interdependence indicates that signals from podocytes influence PEC behavior and vice versa. Immune-renal cell crosstalk controls crescent formation in autoimmune kidney disease, showing that inflammatory signals regulate PEC activation. The ALDH1A2-mediated retinoic acid pathway in PECs suggests a metabolic regulatory input. Ex vivo glomerular outgrowth assays provide a way to analyze pathways involved in PEC activation. Because the cited literature does not establish a single master regulator, researchers should test candidate pathways causally rather than assume a universal mechanism.
glomerular parietal epithelial cell development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALDH1A2 | PEC retinoic acid synthesis and maturation | Knockout or overexpression in PEC-like cells followed by single-cell RNA sequencing |
| CD44 | PEC activation in crescentic glomerulonephritis | Knockout in ex vivo glomerular outgrowth assays |
| CXCR4 | Immune-renal crosstalk and crescent formation | Point-mutation or knockout in autoimmune kidney disease models |
| NPHS2 | Podocyte-PEC interdependence and podocyte depletion | Knock-in of disease-associated variants in podocyte-PEC co-culture |
| ACTA2 | PEC activation and myofibroblast-like phenotype | Overexpression or tagged knock-in in PEC lineage tracing models |
Crescentic glomerulonephritis
PEC dysfunction is a recognized feature of crescentic glomerulonephritis, where activated PECs contribute to crescent formation. Spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney disease, linking immune signals to PEC behavior. These findings make GO:0072016 directly relevant to a severe, rapidly progressive kidney disease phenotype.
Podocyte depletion and kidney disease progression
Decreased parietal epithelial cell density is linked to podocyte depletion and to predictors of kidney disease progression in human kidneys. This connects the developmental and homeostatic process described by GO:0072016 to measurable clinical risk. Podocyte-PEC interdependence provides a mechanistic framework for interpreting these observations.
Glomerular-tubular crosstalk in chronic kidney disease
Crosstalk between glomeruli and tubules is a broader theme in kidney disease progression. Because PECs line Bowman's capsule and sit at the interface between the glomerular tuft and the tubular compartment, changes in PEC biology may be integrated into nephron-level injury and repair responses.
From glomerular parietal epithelial cell development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene cause PEC activation? | CRISPR knockout in PEC-like cells or ex vivo glomerular outgrowth assay |
| Does a variant alter PEC maturation? | CRISPR point mutation knock-in in a PEC model |
| Can a reporter track PEC lineage? | Tagged knock-in of a fluorescent reporter at a PEC locus |
| Does overexpression of a gene drive crescent formation? | CRISPR overexpression in PEC lineage tracing models |
| Which pathways regulate PEC outgrowth? | Ex vivo glomerular outgrowth with pathway inhibitors |
| How do immune cells influence PECs? | Co-culture or autoimmune kidney disease models with immune-renal crosstalk |
How to Study the glomerular parietal epithelial cell development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ex vivo glomerular outgrowth | PEC activation and migration | Pathway analysis in PEC activation |
| Single-cell RNA sequencing | PEC transcriptomes and metabolic pathways | Localizing ALDH1A2 retinoic acid pathway to PECs |
| Lineage tracing | PEC fate and contribution to crescents | Glomerular development and disease models |
| Immunohistochemistry | PEC density and marker expression | Human kidney disease progression studies |
| Co-culture assays | Immune-renal crosstalk | Crescent formation in autoimmune kidney disease |
| Glomerular-tubular crosstalk models | Nephron-level injury responses | Chronic kidney disease progression |
| CRISPR knockout | Causal role of candidate genes | PEC activation and maturation studies |
| CRISPR knock-in | Effect of specific variants or tags | PEC lineage tracing and variant modeling |
Ex vivo glomerular outgrowth assays
Glomerular outgrowth is an ex vivo assay to analyze pathways involved in parietal epithelial cell activation. It allows researchers to observe PEC migration and outgrowth from isolated glomeruli and to test whether candidate genes or pathways alter this behavior.
Single-cell RNA sequencing
Single-cell RNA sequencing data have been used to locate the ALDH1A2-mediated retinoic acid synthetic pathway to glomerular parietal epithelial cells. This approach is well suited to resolving PEC heterogeneity and maturation states within the glomerulus.
Lineage tracing and imaging
Lineage tracing and imaging are central to studying PEC development and activation in vivo. Podocyte-PEC interdependence has been studied using genetic models and imaging of glomerular development and disease. These methods help determine whether PECs contribute to crescents and repair responses.
Human kidney tissue analysis
Quantitative analysis of human kidney tissue has linked decreased parietal epithelial cell density to podocyte depletion and predictors of kidney disease progression. Such studies are essential for translating mechanistic findings from models to human disease.
How CRISPR Can Be Used to Study GO:0072016 glomerular parietal epithelial cell development
Knockout
CRISPR knockout is used to test whether a candidate gene is required for glomerular parietal epithelial cell development or activation. For example, knocking out CD44 or CXCR4 in PEC models can reveal whether these genes are necessary for PEC activation and crescent formation. Ex vivo glomerular outgrowth assays provide a functional readout after knockout.
Point Mutation
CRISPR point mutation allows researchers to introduce disease-associated variants into PEC models without altering the rest of the genome. This is useful when a variant in a podocyte or PEC gene is suspected to alter podocyte-PEC interdependence or PEC maturation. Point mutations can be combined with single-cell RNA sequencing to assess transcriptomic consequences.
Knock-in
CRISPR knock-in can be used to add fluorescent reporters or tags to PEC genes, enabling lineage tracing and live imaging of PEC development and activation. Tagged knock-in of genes such as ALDH1A2 can help map the retinoic acid synthetic pathway in PECs. Knock-in models are also useful for tracking PEC contributions to crescents in disease models.
Overexpression
CRISPR overexpression enables gain-of-function studies to test whether a gene is sufficient to drive PEC activation or crescent formation. Overexpressing ACTA2 or TGFB1 in PEC models can probe myofibroblast-like activation. Overexpression of immune-renal crosstalk mediators such as MIF can test their role in crescent formation.
How EDITGENE Supports glomerular parietal epithelial cell development Research
Researchers studying glomerular parietal epithelial cell development-related genes often need to determine whether a candidate gene is causally involved in PEC formation, maturation, activation, or barrier function. Observational data from single-cell RNA sequencing and human kidney tissue can nominate candidates such as ALDH1A2, CD44, or CXCR4, but causal testing requires controlled genetic perturbation. EDITGENE provides the CRISPR cell models and screening services needed to move from correlation to mechanism in this specialized glomerular cell type.
Contact EDITGENE today to design your custom CRISPR model for glomerular parietal epithelial cell development research.
Frequently Asked Questions About glomerular parietal epithelial cell development
What is GO:0072016?
GO:0072016 is the Gene Ontology biological process term for glomerular parietal epithelial cell development, defined as the progression of a glomerular parietal epithelial cell from its formation to the mature structure.
What are glomerular parietal epithelial cells?
Glomerular parietal epithelial cells are specialized epithelial cells that form tight junctions as a barrier to protein transport and line Bowman's capsule.
What genes are involved in glomerular parietal epithelial cell development?
Genes implicated in PEC biology include ALDH1A2, CD44, CXCR4, ACTA2, and podocyte genes such as NPHS1 and NPHS2 that participate in podocyte-PEC interdependence.
How are parietal epithelial cells linked to kidney disease?
PEC dysfunction is a feature of crescentic glomerulonephritis, and decreased PEC density is linked to podocyte depletion and predictors of kidney disease progression in human kidneys.
What is the role of ALDH1A2 in parietal epithelial cells?
Single-cell RNA sequencing data have localized the ALDH1A2-mediated retinoic acid synthetic pathway to glomerular parietal epithelial cells.
How can I study parietal epithelial cell activation?
Ex vivo glomerular outgrowth is an assay to analyze pathways involved in parietal epithelial cell activation.
Do parietal epithelial cells interact with podocytes?
Yes, podocyte-PEC interdependence is a recognized concept in glomerular development and disease.
What diseases involve parietal epithelial cell dysfunction?
Crescentic glomerulonephritis is a major disease context for PEC dysfunction, and PEC changes are also linked to kidney disease progression.
What CRISPR models are useful for PEC research?
Knockout, point mutation, knock-in, and overexpression models can test causal roles of candidate genes in PEC development and activation.
Why is Bowman's capsule development a synonym for GO:0072016?
The synonym Bowman's capsule development reflects the anatomical location and context of glomerular parietal epithelial cell development.
Conclusion
GO:0072016, glomerular parietal epithelial cell development, captures the formation and maturation of PECs that line Bowman's capsule and form tight junctions as a barrier to protein transport. The cited literature shows that PECs are active participants in glomerular development and disease, with interdependence with podocytes, activation in crescentic glomerulonephritis, and links between PEC density and kidney disease progression. Single-cell RNA sequencing has begun to define PEC-specific pathways such as ALDH1A2-mediated retinoic acid synthesis. Causal testing with CRISPR models and ex vivo assays will be essential to move this field forward.
References
- 1. Bronstein R et al.. 2023. Podocyte-Parietal Epithelial Cell Interdependence in Glomerular Development and Disease.. J Am Soc Nephrol 34(5):737-750 PMID: 36800545
- 2. Fogo AB et al.. 2025. Crosstalk between glomeruli and tubules.. Nat Rev Nephrol 21(3):189-199 PMID: 39643696
- 3. Sultana Z et al.. 2025. Spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney disease.. Nat Immunol 26(11):1977-1988 PMID: 41028563
- 4. Wong MN et al.. 2021. Parietal epithelial cell dysfunction in crescentic glomerulonephritis.. Cell Tissue Res 385(2):345-354 PMID: 34453566
- 5. Liu WB et al.. 2024. Single-cell RNA sequencing data locate ALDH1A2-mediated retinoic acid synthetic pathway to glomerular parietal epithelial cells.. Exp Biol Med (Maywood) 249:10167 PMID: 39360029
- 6. Eymael J et al.. 2020. Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation.. J Vis Exp PMID: 32894262
- 7. Ference-Salo JT et al.. 2025. Decreased parietal epithelial cell density is linked to podocyte depletion and predictors of kidney disease progression in human kidneys.. Am J Physiol Renal Physiol 329(5):F673-F684 PMID: 41052018
- 8. Shankland SJ et al.. 2013. Glomerular parietal epithelial cells in kidney physiology, pathology, and repair.. Curr Opin Nephrol Hypertens 22(3):302-9 PMID: 23518463
